In addition, drugs targeting STAT3, reactive oxygen species (ROS), PAR1, PAK4, apoptosis proteins, and ubiquitin-specific protease 14 (USP14) are also among our top predicted efficacious candidates in treating GBM. This evidence concerns the gene STAT3 and glioblastoma.